Functional Genomics of Brain Aging and Alzheimer’s Disease: Focus on Selective Neuronal Vulnerability
暂无分享,去创建一个
[1] J. Loring,et al. Selectively Reduced Expression of Synaptic Plasticity-Related Genes in Amyloid Precursor Protein + Presenilin-1 Transgenic Mice , 2003, The Journal of Neuroscience.
[2] S. Haga,et al. Demonstration of microglial cells in and around senile (neuritic) plaques in the Alzheimer brain , 1989, Acta Neuropathologica.
[3] A. Lustig,et al. Alterations in immunological and neurological gene expression patterns in Alzheimer's disease tissues. , 2007, Experimental cell research.
[4] Richard J. Caselli,et al. Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging , 2010, NeuroImage.
[5] Andrei G. Vlassenko,et al. Regional aerobic glycolysis in the human brain , 2010, Proceedings of the National Academy of Sciences.
[6] L. Lue,et al. Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. , 1996, Journal of neuropathology and experimental neurology.
[7] N. Raz,et al. Differential Aging of the Brain: Patterns, Cognitive Correlates and Modifiers , 2022 .
[8] M. Michaelis,et al. Genomic and biochemical approaches in the discovery of mechanisms for selective neuronal vulnerability to oxidative stress , 2009, BMC Neuroscience.
[9] G. Cosnard,et al. Comparison of regional cerebral blood flow and glucose metabolism in the normal brain: effect of aging , 2000, Journal of the Neurological Sciences.
[10] A. Smith,et al. Genome wide profiling of altered gene expression in the neocortex of Alzheimer's disease , 2009, Journal of neuroscience research.
[11] M. Gallagher,et al. Preserved neuron number in the hippocampus of aged rats with spatial learning deficits. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] O. Sorgenfrei,et al. Laser microdissection in CNS research. , 2005, Drug discovery today.
[13] P. Greengard,et al. Synapsin I (protein I) in different brain regions in senile dementia of Alzheimer type and in multiinfarct dementia , 2005, Journal of Neural Transmission.
[14] O. Ottersen,et al. Genome instability and DNA repair in brain, ageing and neurological disease , 2007, Neuroscience.
[15] J. Mazziotta,et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Troncoso,et al. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease , 1994, The Lancet.
[17] A. Convit,et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD , 2001, Neurobiology of Aging.
[18] Kevin Cox,et al. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex , 1990, The Journal of comparative neurology.
[19] D. Salmon,et al. Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.
[20] P. Eikelenboom,et al. Role of microglia in plaque formation in senile dementia of the Alzheimer type , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.
[21] R. DeTeresa,et al. Neocortical cell counts in normal human adult aging , 1987, Annals of neurology.
[22] A. Alavi,et al. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] R. Swerdlow,et al. The Alzheimer's disease mitochondrial cascade hypothesis. , 2010, Journal of Alzheimer's disease : JAD.
[24] Eric M Reiman,et al. Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. , 2007, Physiological genomics.
[25] J. Morris,et al. Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.
[26] Carl W. Cotman,et al. Gene expression changes in the course of normal brain aging are sexually dimorphic , 2008, Proceedings of the National Academy of Sciences.
[27] J. Buxbaum,et al. PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia. , 2009, Archives of neurology.
[28] Z. Khachaturian. Calcium Hypothesis of Alzheimer's Disease and Brain Aging a , 1994, Annals of the New York Academy of Sciences.
[29] P. Mecocci,et al. Oxidative damage to mitochondrial DNA shows marked age‐dependent increases in human brain , 1993, Annals of neurology.
[30] K. Ishii,et al. Low cerebral glucose extraction rates in the human medial temporal cortex and cerebellum , 2000, Journal of the Neurological Sciences.
[31] Eric M Reiman,et al. Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. , 2008, Physiological genomics.
[32] E. Jazin,et al. Alzheimer's disease: mRNA expression profiles of multiple patients show alterations of genes involved with calcium signaling , 2006, Neurobiology of Disease.
[33] D. Selkoe,et al. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior , 2008, Behavioural Brain Research.
[34] C. White,et al. The role of cortical connectivity in Alzheimer's disease pathogenesis: A review and model system , 1993, Neurobiology of Aging.
[35] P. Mcgeer,et al. Immune System Response in Alzheimer's Disease , 1989, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[36] Xue-wen Chen,et al. High intrinsic oxidative stress may underlie selective vulnerability of the hippocampal CA1 region. , 2005, Brain research. Molecular brain research.
[37] J. Bauer,et al. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[38] P. Zuo,et al. Gene expression profile of amyloid beta protein-injected mouse model for Alzheimer disease , 2005, Acta Pharmacologica Sinica.
[39] A. Nappi,et al. Alzheimer ' s Disease : Cell-Specific Pathology Isolates the Hippocampal Formation , 2022 .
[40] D. Selkoe,et al. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.
[41] J. Morrison,et al. Life and death of neurons in the aging brain. , 1997, Science.
[42] M. Laakso,et al. Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue , 1999, Acta Neuropathologica.
[43] H. Chui,et al. MHC class II‐positive microglia in human brain: Association with alzheimer lesions , 1992, Journal of neuroscience research.
[44] R. Anwyl,et al. Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction. , 2007, Biochemical Society transactions.
[45] M. Mattson,et al. Ageing and neuronal vulnerability , 2006, Nature Reviews Neuroscience.
[46] M. Beal,et al. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age , 1992, Nature Genetics.
[47] Soo‐Young Choi,et al. Oligonucleotide-based Analysis of Differentially Expressed Genes in Hippocampus of Transgenic Mice Expressing NSE-controlled APPsw , 2006, Neurochemical Research.
[48] J Clinton,et al. Differential synaptic loss in the cortex in Alzheimer's disease: a study using archival material. , 1994, Neuroreport.
[49] W. Markesbery,et al. Incipient Alzheimer's disease: Microarray correlation analyses reveal major transcriptional and tumor suppressor responses , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[50] Richard Hollister,et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.
[51] M. Ball,et al. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling , 2002, Journal of neuroscience research.
[52] N. Schuff,et al. Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4T , 2007, Neurobiology of Aging.
[53] D. Bennett,et al. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment , 2001, Annals of neurology.
[54] H. Braak,et al. Alzheimer's disease affects limbic nuclei of the thalamus , 2004, Acta Neuropathologica.
[55] F. Iannotti,et al. Differential Vulnerability of the CA1 and CA3 Subfields of the Hippocampus to Superoxide and Hydroxyl Radicals In Vitro , 1997, Journal of neurochemistry.
[56] D. Bozyczko‐Coyne,et al. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease , 2006, Neurobiology of Aging.
[57] M. Witter,et al. Functional organization of the extrinsic and intrinsic circuitry of the parahippocampal region , 1989, Progress in Neurobiology.
[58] K. Mirnics,et al. Molecular signatures of neurodegeneration in the cortex of PS1/PS2 double knockout mice , 2008, Molecular Neurodegeneration.
[59] M. Mattson,et al. Gene expression atlas of the mouse central nervous system: impact and interactions of age, energy intake and gender , 2007, Genome Biology.
[60] L. Martin,et al. Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer’s disease brains , 2000, Journal of the Neurological Sciences.
[61] D. Harman. Aging: a theory based on free radical and radiation chemistry. , 1956, Journal of gerontology.
[62] L. Massieu,et al. Selective vulnerability of brain regions to oxidative stress in a non-coma model of insulin-induced hypoglycemia , 2010, Neuroscience.
[63] P. Lantos,et al. β‐Amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer’s disease , 1999 .
[64] Christopher M. Overall,et al. Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology , 2009, Trends in Neurosciences.
[65] F. Schmitt,et al. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment , 2007, Neurology.
[66] P. Eikelenboom,et al. Complement activation in amyloid plaques in Alzheimer’s dementia , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.
[67] J. Baron,et al. The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization. , 1998, Brain : a journal of neurology.
[68] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[69] G. V. Van Hoesen,et al. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. , 1991, Cerebral cortex.
[70] R N Kalaria,et al. Microglia and Alzheimer's disease. , 1999, Current opinion in hematology.
[71] J. Morrison,et al. Determinants of neuronal vulnerability in neurodegenerative diseases , 1998, Annals of neurology.
[72] A D Roses,et al. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease , 2009, The Pharmacogenomics Journal.
[73] E. Eichler,et al. Regional patterns of gene expression in human and chimpanzee brains. , 2004, Genome research.
[74] W. Scheper,et al. The significance of neuroinflammation in understanding Alzheimer’s disease , 2006, Journal of Neural Transmission.
[75] C. Bertoni‐Freddari,et al. Age-related decline in metabolic competence of small and medium-sized synaptic mitochondria , 2005, Naturwissenschaften.
[76] Xinkun Wang,et al. Frontiers in Aging Neuroscience Aging Neuroscience Review Article , 2022 .
[77] C. Barnes,et al. Neural plasticity in the ageing brain , 2006, Nature Reviews Neuroscience.
[78] C. Plata-salamán,et al. Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.
[79] Hideo Tsukada,et al. Age-related changes in cerebral blood flow and glucose metabolism in conscious rhesus monkeys , 2002, Brain Research.
[80] D. Price,et al. Dysfunction and death of neurons in human degenerative neurological diseases and in animal models. , 1987, Ciba Foundation symposium.
[81] N. Gerry,et al. Reliability and reproducibility of gene expression measurements using amplified RNA from laser-microdissected primary breast tissue with oligonucleotide arrays. , 2005, The Journal of molecular diagnostics : JMD.
[82] Karen M Rodrigue,et al. Brain Aging and Its Modifiers , 2007, Annals of the New York Academy of Sciences.
[83] Zaven S. Khachaturian,et al. Hypothesis on the Regulation of Cytosol Calcium Concentration and the Aging Brain , 1987, Neurobiology of Aging.
[84] R. Busuttil,et al. Genome dynamics and transcriptional deregulation in aging , 2007, Neuroscience.
[85] B. Vogt,et al. Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer's disease , 2004, Acta Neuropathologica.
[86] M. Tabaton,et al. Microarray Analysis in Alzheimer's Disease and Normal Aging , 2004, IUBMB life.
[87] B. Shukitt-Hale,et al. Aging modifies brain region-specific vulnerability to experimental oxidative stress induced by low dose hydrogen peroxide , 2007, AGE.
[88] J M Lee,et al. A gene expression profile of Alzheimer's disease. , 2001, DNA and cell biology.
[89] G. Mathern,et al. Human Fascia Dentata Anatomy and Hippocampal Neuron Densities Differ Depending on the Epileptic Syndrome and Age at First Seizure , 1997, Journal of neuropathology and experimental neurology.
[90] M. Starkey,et al. Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease , 2007, Brain Research.
[91] T. Cowen. Selective vulnerability in adult and ageing mammalian neurons , 2002, Autonomic Neuroscience.
[92] E. Michaelis,et al. Open Access Research Article Transcriptomic Responses in Mouse Brain Exposed to Chronic Excess of the Neurotransmitter Glutamate , 2022 .
[93] E. Fuchs,et al. A molecular blueprint of gene expression in hippocampal subregions CA1, CA3, and DG is conserved in the brain of the common marmoset , 2009, Hippocampus.
[94] K Kosaka,et al. Up-regulation of calcineurin Abeta mRNA in the Alzheimer's disease brain: assessment by cDNA microarray. , 2001, Biochemical and biophysical research communications.
[95] Philipp Khaitovich,et al. Aging and Gene Expression in the Primate Brain , 2005, PLoS biology.
[96] M J Campbell,et al. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[97] G K Wilcock,et al. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[98] A. Czernik,et al. Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique , 2001, Neuroscience Letters.
[99] W. Honer,et al. Regional synaptic pathology in Alzheimer's disease , 1992, Neurobiology of Aging.
[100] G. Alexander,et al. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. , 2002, The American journal of psychiatry.
[101] Ludovico Minati,et al. Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review , 2009, American journal of Alzheimer's disease and other dementias.
[102] J. Trojanowski,et al. Expression profile of transcripts in Alzheimer's disease tangle‐bearing CA1 neurons , 2000, Annals of neurology.
[103] P. Lantos,et al. beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. , 1999, Neuropathology and applied neurobiology.
[104] M. Bobinski,et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[105] Patrick L. McGeer,et al. Inflammation, autotoxicity and Alzheimer disease , 2001, Neurobiology of Aging.
[106] John X. Morris,et al. Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition , 2010, Proceedings of the National Academy of Sciences.
[107] Y Yonekura,et al. Altered cerebral energy metabolism in Alzheimer's disease: a PET study. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[108] M. J. Wade,et al. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. , 2001, Archives of neurology.
[109] R. Myers,et al. DNA microarray analysis of functionally discrete human brain regions reveals divergent transcriptional profiles , 2003, Neurobiology of Disease.
[110] Timo Grimmer,et al. Cerebral Metabolic Correlates of the Clinical Dementia Rating Scale in Mild Cognitive Impairment , 2007, Journal of geriatric psychiatry and neurology.
[111] Patrick R Hof,et al. Selective vulnerability of corticocortical and hippocampal circuits in aging and Alzheimer's disease. , 2002, Progress in brain research.
[112] I. Kohane,et al. Gene regulation and DNA damage in the ageing human brain , 2004, Nature.
[113] R. Schmidt-Kastner,et al. Selective vulnerability of the hippocampus in brain ischemia , 1991, Neuroscience.
[114] P. Coleman,et al. Defects in expression of genes related to synaptic vesicle traffickingin frontal cortex of Alzheimer’s disease , 2003, Neurobiology of Disease.
[115] Winnie S. Liang,et al. Alzheimer's disease is associated with reduced expression of energy metabolism genes in posterior cingulate neurons , 2008, Proceedings of the National Academy of Sciences.
[116] Patrick R Hof,et al. Life and death of neurons in the aging cerebral cortex. , 2007, International review of neurobiology.
[117] H. Braak,et al. The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases , 1992, Neuroscience Research.
[118] Cheryl L. Dahle,et al. Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. , 2005, Cerebral cortex.
[119] M. O’Banion,et al. Regional neuronal loss in aging and Alzheimer's disease: a brief review , 1994 .
[120] E. Mufson,et al. Gene Expression Profiles of Cholinergic Nucleus Basalis Neurons in Alzheimer's Disease , 2002, Neurochemical Research.
[121] T. Kadar,et al. Sub-regional hippocampal vulnerability in various animal models leading to cognitive dysfunction , 1998, Journal of Neural Transmission.
[122] L. Honig,et al. Model‐guided microarray implicates the retromer complex in Alzheimer's disease , 2005, Annals of neurology.
[123] Alan C. Evans,et al. Brain development during childhood and adolescence: a longitudinal MRI study , 1999, Nature Neuroscience.
[124] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[125] S. Styren,et al. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease , 1988, Neurobiology of Aging.
[126] D. Mann,et al. A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease , 1987, Journal of the Neurological Sciences.
[127] D. Stein,et al. Greater Metabolic Rate Decreases in Hippocampal Formation and Proisocortex than in Neocortex in Alzheimer’s Disease , 1997, Neuropsychobiology.
[128] C. Geula,et al. Selective age-related loss of CALBINDIN-D28k from basal forebrain cholinergic neurons in the common marmoset (callithrix jacchus) , 2003, Neuroscience.
[129] A. Graybiel,et al. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.